ÎÚÑ»´«Ã½

To see details on future events, please see our calendar. For past events, check out our photos.

 March 2013
Infectious disease experts at Johns Hopkins have found that among people infected with the hepatitis C virus (HCV), co-infection with HIV speeds damage and scarring of liver tissue by almost a decade. In a second study of HCV infection, the Johns Hopkins research team participated in the discovery of two genetic mutations that make it more likely that patients’ immune systems can rid the body of HCV. Both studies are described in articles published in the journal Annals of Internal Medicine.

 [Radio interview; Air date June 24, 2012]
The Johns ÎÚÑ»´«Ã½ ALIVE program, or AIDS Linked to the Intravenous Experience, is celebrating 25 years of research into HIV and injection drug use. A large part of the program's success can be attributed to a single person known as Bert. In a special field piece, Scott Goldberg chronicles Bert’s amazing journey from a heroin user to valued employee of the ALIVE program who is responsible for tracking down study participants who have missed visits.

, November 2007
Celebrating two decades of research on HIV infection among injection drug users, the AIDS Linked to the IntraVenous Experience (ALIVE) study has become the longest-running investigation of its kind and has made myriad contributions to the study of HIV/AIDS. Based at the Johns ÎÚÑ»´«Ã½ and conducted in Baltimore, Maryland, ALIVE is an observational cohort study that tracks approximately 3,000 injection drug users. Developed in 1987, the community-based study is funded by grants from the National Institute of Drug Abuse (NIDA).